Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001520897 | SCV001730110 | benign | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2022-07-06 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294468 | SCV002587431 | likely benign | Focal segmental glomerulosclerosis | 2018-07-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003931127 | SCV004746635 | likely benign | INF2-related disorder | 2019-05-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |